TCM
Tamarack Capital Management Portfolio holdings
AUM
$503M
This Quarter Return
+1.33%
1 Year Return
+15.45%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$592M
AUM Growth
+$592M
(+11%)
Cap. Flow
+$58.3M
Cap. Flow
% of AUM
9.86%
Top 10 Holdings %
Top 10 Hldgs %
65.13%
Holding
44
New
7
Increased
16
Reduced
6
Closed
10
Top Buys
| 1 |
PDCO
Patterson Companies, Inc.
PDCO
|
$26.1M |
| 2 |
Becton Dickinson
BDX
|
$24.2M |
| 3 |
Quest Diagnostics
DGX
|
$21.8M |
| 4 |
Lantheus
LNTH
|
$11M |
| 5 |
Alkermes
ALKS
|
$10.3M |
Top Sells
| 1 |
Teva Pharmaceuticals
TEVA
|
$24.9M |
| 2 |
Inogen
INGN
|
$21.2M |
| 3 |
DexCom
DXCM
|
$14M |
| 4 |
Pfizer
PFE
|
$13.6M |
| 5 |
KERX
Keryx Biopharmaceuticals Inc
KERX
|
$12.1M |
Sector Composition
| 1 | Healthcare | 83.75% |
| 2 | Technology | 2.83% |
| 3 | Industrials | 0.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ELGX
1
DELISTED
Endologix Inc
ELGX
| $62.1M | 7.14% | 4,050,000 +50,000 | +1% | +$767K |
|
|
2
Becton Dickinson
BDX
$55.3B
| $56.7M | 6.51% | 400,000 +171,000 | +75% | +$24.2M |
|
|
3
Quest Diagnostics
DGX
$20.3B
| $50.8M | 5.84% | 700,000 +300,000 | +75% | +$21.8M |
|
|
PDCO
4
DELISTED
Patterson Companies, Inc.
PDCO
| $41.6M | 4.78% | 855,000 +537,055 | +169% | +$26.1M |
|
5
Integer Holdings
ITGR
$3.78B
| $39M | 4.49% | 723,962 +150,031 | +26% | +$8.09M |
|
6
Medtronic
MDT
$119B
| $37.1M | 4.26% | 500,000 +125,000 | +33% | +$9.26M |
|
|
7
Alkermes
ALKS
$4.78B
| $25.7M | 2.96% | 400,000 +160,000 | +67% | +$10.3M |
|
|
MDRX
8
DELISTED
Veradigm Inc. Common Stock
MDRX
| $24.3M | 2.79% | 1,775,000 +275,000 | +18% | +$3.76M |
|
|
SPNC
9
DELISTED
Spectranetics Corp
SPNC
| $24.2M | 2.78% | 1,050,000 -27,596 | -3% | -$635K |
|
|
NXTM
10
DELISTED
NxStage Medical Inc.
NXTM
| $23.9M | 2.75% | 1,675,000 +375,000 | +29% | +$5.36M |
|
11
AtriCure
ATRC
$1.84B
| $21.8M | 2.51% | 885,000 +85,000 | +11% | +$2.09M |
|
12
Bio-Rad Laboratories Class A
BIO
$8.06B
| $18.2M | 2.1% | 121,050 +13,050 | +12% | +$1.97M |
|
|
LMNX
13
DELISTED
Luminex Corp
LMNX
| $17.3M | 1.98% | 1,000,000 +366,908 | +58% | +$6.33M |
|
|
IMPR
14
DELISTED
IMPRIVATA, INC COM
IMPR
| $16.8M | 1.93% | 1,025,000 +595,739 | +139% | +$9.75M |
|
15
MiMedx Group
MDXG
$1.05B
| $15.1M | 1.73% | 1,300,000 +300,000 | +30% | +$3.48M |
|
|
SRGA
16
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
| $12.9M | 1.49% | 2,000,000 | – | – |
|
|
CTRX
17
DELISTED
CATAMARAN CORP COM STK (CDA)
CTRX
| $11.6M | 1.33% | 189,802 -60,198 | -24% | -$3.68M |
|
|
18
Lantheus
LNTH
$3.73B
| $11M | 1.26% | +1,770,918 | New | +$11M |
|
19
Bruker
BRKR
$5.16B
| $10.2M | 1.18% | +500,709 | New | +$10.2M |
|
20
ICU Medical
ICUI
$3.15B
| $10.1M | 1.16% | 105,776 +70,776 | +202% | +$6.77M |
|
|
CORI
21
DELISTED
Corium International, Inc.
CORI
| $9.85M | 1.13% | 719,385 -59,536 | -8% | -$815K |
|
22
Perrigo
PRGO
$3.27B
| $9.24M | 1.06% | 50,000 -52,000 | -51% | -$9.61M |
|
23
Bio-Techne
TECH
$8.5B
| $7.95M | 0.91% | 80,779 -34,221 | -30% | -$3.37M |
|
|
AMRN
24
Amarin Corp
AMRN
$311M
| $7.93M | 0.91% | +3,224,690 | New | +$7.93M |
|
|
OXFD
25
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
| $6.99M | 0.8% | 504,668 +52,535 | +12% | +$728K |
|